OpZira, Inc.

About OpZira, Inc.

OpZira, Inc. is a forward-thinking ophthalmic medical device company founded on a legacy of research excellence. We deliver innovative technologies designed to enhance the detection and monitoring of ocular disease. AdaptDx Pro® is a wearable dark adaptometer used to measure dark adaptation speed. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often one of the first functional signs of retinal disease. AdaptDx Pro is available in the U.S. NOVA™ Vision Testing System is an electrophysiology platform that provides objective assessments of the visual and neuro-visual pathway. VEP is available in the U.S. and select international markets. ERG is available outside of the U.S. For more information, visit OpZira.com.